GLP-1 medications reduce thirst cues and daily fluid intake, creating conditions where creatine's kidney demands are harder to meet
Designed for training supporttake one tablet twice daily or two tablets 30-60 minutes before exercise for optimal results
Machine learning models are being used to identify novel GLP-1 analogs with improved efficacy and safety profiles, reducing the time and cost of R&D
PSPeptides operates within this regulatory framework by selling exclusively for laboratory and research use, providing full documentation including batch-specific COAs, and maintaining transparent labeling on all products
While promising, these arent yet widely available and more research is needed to confirm their long-term effectiveness and safety
See recent WSJ article here Enthusiasts (biohackers?) and some longevity-focused clinicians believe that microdosing these drugs offers benefits beyond weight loss, such as improved metabolic health, glycemic control, reduced systemic inflammation, and potentially even a lower risk of age-related diseases